First-line chemotherapy regimens and hematologic response
| . | n . | CR . | VGPR . | PR . | NR . |
|---|---|---|---|---|---|
| Thalidomide based | 11 | 3 | 2 | 1 | 5 |
| Bortezomib based | 9 | 8 | 0 | 1 | 0 |
| Alkylator based | 6 | 3 | 1 | 1 | 1 |
| Melphalan autologous stem cell transplant | 4 | 4 | 0 | 0 | 0 |
| Lenalidomide based | 1 | 0 | 0 | 1 | 0 |
| Steroids alone | 1 | 0 | 0 | 0 | 1 |
| . | n . | CR . | VGPR . | PR . | NR . |
|---|---|---|---|---|---|
| Thalidomide based | 11 | 3 | 2 | 1 | 5 |
| Bortezomib based | 9 | 8 | 0 | 1 | 0 |
| Alkylator based | 6 | 3 | 1 | 1 | 1 |
| Melphalan autologous stem cell transplant | 4 | 4 | 0 | 0 | 0 |
| Lenalidomide based | 1 | 0 | 0 | 1 | 0 |
| Steroids alone | 1 | 0 | 0 | 0 | 1 |